We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine
ReviewFree Access

Virulence determinants of high-pathogenic avian influenza viruses in gallinaceous poultry

    Jürgen Stech

    * Author for correspondence

    Institute of Molecular Biology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, 17493 Greifswald-Insel Riems, Germany.

    &
    Thomas C Mettenleiter

    Institute of Molecular Biology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, 17493 Greifswald-Insel Riems, Germany

    Published Online:https://doi.org/10.2217/fvl.13.27

    High-pathogenic avian influenza viruses (HPAIV) cause devastating outbreaks in domestic poultry worldwide. Moreover, they repeatedly lead to severe, even fatal disease in humans, raising concerns about their pandemic potential. HPAIV have evolved from circulating low-pathogenic precursors in several independent events by spontaneous acquisition of a polybasic cleavage site in the hemagglutinin (HA) envelope protein. Remarkably, in nature, HPAIV are confined to the HA serotypes H5 and H7 from the 16 HA serotypes known in birds. However, experimental introduction of a polybasic cleavage site into non-H5/H7 HA may result in a highly pathogenic phenotype, indicating that emergence of HPAIV with novel serotypes is conceivable, but requires further adaptation to the chicken host.

    Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

    References

    • Alexander DJ. A review of avian influenza in different bird species. Vet. Microbiol.74(1–2),3–13 (2000).
    • Werner O. Classic fowl plague – a review. Berl. Munch Tierarztl. Wochenschr.119(3–4),140–150 (2006).
    • Swayne DE, Pantin-Jackwood M. Pathogenicity of avian influenza viruses in poultry. Dev. Biol. (Basel)124,61–67 (2006).
    • Swayne DE. Understanding the complex pathobiology of high pathogenicity avian influenza viruses in birds. Avian Dis.51(Suppl. 1),242–249 (2007).
    • Alexander DJ. Avian influenza. In: Manual of Diagnostic Tests & Vaccines for Terrestrial Animals (6th Edition). World Organisation for Animal Health, France, 465–481 (2008).
    • Soda K, Asakura S, Okamatsu M, Sakoda Y, Kida H. H9N2 influenza virus acquires intravenous pathogenicity on the introduction of a pair of di-basic amino acid residues at the cleavage site of the hemagglutinin and consecutive passages in chickens. Virol. J.8(1),64 (2011).
    • Veits J, Romer-Oberdorfer A, Helferich D et al. Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions. Vaccine26(13),1688–1696 (2008).
    • Rudolf M, Poppel M, Frohlich A et al. Longitudinal 2 years field study of conventional vaccination against highly pathogenic avian influenza H5N1 in layer hens. Vaccine28(42),6832–6840 (2010).
    • van der Goot JA, Koch G, de Jong MC, van Boven M. Quantification of the effect of vaccination on transmission of avian influenza (H7N7) in chickens. Proc. Natl Acad. Sci. USA102(50),18141–18146 (2005).
    • 10  van der Goot JA, van Boven M, Koch G, de Jong MC. Variable effect of vaccination against highly pathogenic avian influenza (H7N7) virus on disease and transmission in pheasants and teals. Vaccine25(49),8318–8325 (2007).
    • 11  Klenk HD, Matrosovich, MN, Stech J. Avian influenza: molecular mechanisms of pathogenesis and host range. In: Animal Viruses: Molecular Biology. Mettenleiter TC, Sobrino F (Eds). Caister Academic Press, UK, 253–303 (2007).
    • 12  Subbarao K, Klimov A, Katz J et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science279(5349),393–396 (1998).
    • 13  Claas EC, Osterhaus AD, van Beek R et al. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet351(9101),472–477 (1998).
    • 14  van Kolfschooten F. Dutch veterinarian becomes first victim of avian influenza. Lancet361(9367),1444 (2003).
    • 15  Fouchier RA, Schneeberger PM, Rozendaal FW et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc. Natl Acad. Sci. USA101(5),1356–1361 (2004).
    • 16  Puthavathana P, Auewarakul P, Charoenying PC et al. Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand. J. Gen. Virol.86(Pt 2),423–433 (2005).
    • 17  de Jong MD, Simmons CP, Thanh TT et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med.12(10),1203–1207 (2006).
    • 18  Alexander DJ, Brown IH. History of highly pathogenic avian influenza. Rev. Sci. Tech.28(1),19–38 (2009).
    • 19  Schaefer W. [Comparative sero-immunological studies of the viruses of influenza and classical fowl plague.] Z. Naturforsch.10(B),81–91 (1955).
    • 20  International Committee on Taxonomy of Viruses. Virus Taxonomy: Ninth Report of the International Committee on Taxonomy of Viruses. King AMQ, Lefkowitz E, Adams MJ, Carstens EB (Eds). Academic Press, London, UK (2012).
    • 21  WHO. Expert committee on influenza, first report. World Health Organ. Tech. Rep. Ser.6(64),1–32 (1953).
    • 22  McGeoch D, Fellner P, Newton C. Influenza virus genome consists of eight distinct RNA species. Proc. Natl Acad. Sci. USA73(9),3045–3049 (1976).
    • 23  Ritchey MB, Palese P, Kilbourne ED. RNAs of influenza A, B, and C viruses. J. Virol.18(2),738–744 (1976).
    • 24  Palese P, Shaw ML. Orthomyxoviridae: the viruses and their replication. In: Fields Virology (5th Edition). Knipe DM, Howley PM (Eds). Lippincott Williams & Wilkins, PA, USA, 1647–1690 (2007).
    • 25  Klenk HD, Rott R, Orlich M, Blodorn J. Activation of influenza A viruses by trypsin treatment. Virology68(2),426–439 (1975).
    • 26  Lazarowitz SG, Choppin PW. Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide. Virology68(2),440–454 (1975).
    • 27  Maeda T, Ohnishi S. Activation of influenza virus by acidic media causes hemolysis and fusion of erythrocytes. FEBS Lett.122(2),283–287 (1980).
    • 28  Huang RTC, Wahn K, Klenk HD, Rott R. Fusion between cell membranes and liposomes containing the glycoprotein of influenza virus. Virology104(2),294–302 (1980).
    • 29  White JM, Matlin K, Helenius A. Cell fusion by Semliki Forest, influenza, and vesicular stomatitis viruses. J. Cell. Biol.89(3),674–679 (1981).
    • 30  Bottcher E, Matrosovich T, Beyerle M et al. Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J. Virol.80(19),9896–9898 (2006).
    • 31  Bottcher-Friebertshauser E, Freuer C, Sielaff F et al. Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors. J. Virol.84(11),5605–5614 (2010).
    • 32  Bertram S, Glowacka I, Blazejewska P et al. TMPRSS2 and TMPRSS4 facilitate trypsin-independent spread of influenza virus in Caco-2 cells. J. Virol.84(19),10016–10025 (2010).
    • 33  Baron J, Tarnow C, Mayoli-Nussle D et al. Matriptase, HAT and TMPRSS2 activate the hemagglutinin of H9N2 influenza A viruses. J. Virol.87(3),1811–1820 (2012).
    • 34  Hamilton BS, Gludish DW, Whittaker GR. Cleavage activation of the human-adapted influenza virus subtypes by matriptase reveals both subtype and strain specificities. J. Virol.86(19),10579–10586 (2012).
    • 35  Bertram S, Heurich A, Lavender H et al. Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts. PLoS ONE7(4),e35876 (2012).
    • 36  Garten W, Bosch FX, Linder D, Rott R, Klenk HD. Proteolytic activation of the influenza virus hemagglutinin: the structure of the cleavage site and the enzymes involved in cleavage. Virology115(2),361–374 (1981).
    • 37  Stieneke-Groeber A, Vey M, Angliker H et al. Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J.11(7),2407–2414 (1992).▪ Evidence that furin activates the hemagglutinin (HA) of high-pathogenic avian influenza viruses (HPAIV).
    • 38  Cox NJ, Subbarao K. Influenza. Lancet354(9186),1277–1282 (1999).
    • 39  Kuiken T, Taubenberger JK. Pathology of human influenza revisited. Vaccine26(Suppl. 4),D59–D66 (2008).
    • 40  Taubenberger JK, Morens DM. The pathology of influenza virus infections. Annu. Rev. Pathol.3,499–522 (2008).
    • 41  Schild GC, Newman RW, Webster RG, Major D, Hinshaw VS. Antigenic analysis of influenza A virus surface antigens: considerations for the nomenclature of influenza virus. Brief review. Arch. Virol.63(3–4),171–184 (1980).
    • 42  Fouchier RA, Munster V, Wallensten A et al. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J. Virol.79(5),2814–2822 (2005).
    • 43  Munster VJ, Baas C, Lexmond P et al. Spatial, temporal, and species variation in prevalence of influenza A viruses in wild migratory birds. PLoS Pathog.3(5),e61 (2007).▪ Most comprehensive analysis of low-pathogenic avian influenza viruses (LPAIV) in wild birds.
    • 44  Kawaoka Y, Webster RG. Evolution of the A/chicken/pennsylvania/83 (H5N2) influenza virus. Virology146(1),130–137 (1985).
    • 45  Webster RG, Kawaoka Y, Bean WJ Jr. Molecular changes in A/chicken/Pennsylvania/83 (H5N2) influenza virus associated with acquisition of virulence. Virology149(2),165–173 (1986).
    • 46  Banks J, Speidel ES, Moore E et al. Changes in the haemagglutinin and the neuraminidase genes prior to the emergence of highly pathogenic H7N1 avian influenza viruses in Italy. Arch. Virol.146(5),963–973 (2001).
    • 47  Capua I, Marangon S. The avian influenza epidemic in Italy, 1999–2000: a review. Avian Pathol.29(4),289–294 (2000).
    • 48  Suarez DL, Senne DA, Banks J et al. Recombination resulting in virulence shift in avian influenza outbreak, Chile. Emerg. Infect. Dis.10(4),693–699 (2004).
    • 49  Pasick J, Handel K, Robinson J et al. Intersegmental recombination between the haemagglutinin and matrix genes was responsible for the emergence of a highly pathogenic H7N3 avian influenza virus in British Columbia. J. Gen. Virol.86(Pt 3),727–731 (2005).
    • 50  Garten W, Klenk HD. Cleavage activation of the influenza virus hemagglutinin and its role in pathogenesis. In: Avian Influenza. Klenk HD, Matrosovich MN, Stech J (Eds). Karger, Switzerland, 156–167 (2008).
    • 51  Roehm C, Horimoto T, Kawaoka Y, Suss J, Webster RG. Do hemagglutinin genes of highly pathogenic avian influenza viruses constitute unique phylogenetic lineages? Virology209(2),664–670 (1995).
    • 52  Khatchikian D, Orlich M, Rott R. Increased viral pathogenicity after insertion of a 28S ribosomal RNA sequence into the haemagglutinin gene of an influenza virus. Nature340(6229),156–157 (1989).▪▪ First evidence that a polybasic HA cleavage site (HACS) can be acquired by recombination.
    • 53  Perdue ML, Garcia M, Senne D, Fraire M. Virulence-associated sequence duplication at the hemagglutinin cleavage site of avian influenza viruses. Virus Res.49(2),173–186 (1997).▪ Hypothesized that a polybasic HACS could be acquired by polymerase slippage during genome replication.
    • 54  Gabriel G, Dauber B, Wolff T et al. The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc. Natl Acad. Sci. USA102(51),18590–18595 (2005).
    • 55  Schrauwen EJ, Herfst S, Leijten LM et al. The multibasic cleavage site in H5N1 virus is critical for systemic spread along the olfactory and hematogenous routes in ferrets. J. Virol.86(7),3975–3984 (2012).
    • 56  Suguitan AL Jr, Matsuoka Y, Lau YF et al. The multibasic cleavage site of the hemagglutinin of highly pathogenic A/Vietnam/1203/2004 (H5N1) avian influenza virus acts as a virulence factor in a host-specific manner in mammals. J. Virol.86(5),2706–2714 (2012).
    • 57  Horimoto T, Kawaoka Y. Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza A virus. J. Virol.68(5),3120–3128 (1994).
    • 58  Gohrbandt S, Veits J, Hundt J et al. Amino acids adjacent to the haemagglutinin cleavage site are relevant for virulence of avian influenza viruses of subtype H5. J. Gen. Virol.92(Pt 1),51–59 (2010).
    • 59  Stech O, Veits J, Weber S et al. Acquisition of a polybasic hemagglutinin cleavage site by a low-pathogenic avian influenza virus is not sufficient for immediate transformation into a highly pathogenic strain. J. Virol.83(11),5864–5868 (2009).▪ First study demonstrating that the artificial introduction of polybasic HACS into a LPAIV may not yield a high-pathogenic phenotype, indicating the existence of further virulence determinants.
    • 60  Veits J, Weber S, Stech O et al. Avian influenza virus hemagglutinins H2, H4, H8, and H14 support a highly pathogenic phenotype. Proc. Natl Acad. Sci. USA109(7),2579–2584 (2012).▪▪ The generation of non-H5/H7 HPAIV suggests the possible emergence of HPAIV with novel HA serotypes.
    • 61  Gohrbandt S, Veits J, Breithaupt A et al. H9 avian influenza reassortant with engineered polybasic cleavage site displays a highly pathogenic phenotype in chicken. J. Gen. Virol.92(Pt 8),1843–1853 (2011).
    • 62  Bogs J, Veits J, Gohrbandt S et al. Highly pathogenic H5N1 influenza viruses carry virulence determinants beyond the polybasic hemagglutinin cleavage site. PLoS ONE5(7),e11826 (2010).
    • 63  Munster VJ, Schrauwen EJ, de Wit E et al. Insertion of a multibasic cleavage motif into the hemagglutinin of a low-pathogenic avian influenza H6N1 virus induces a highly pathogenic phenotype. J. Virol.84(16),7953–7960 (2010).▪ Demonstrates that the artificial introduction of polybasic HACS into a LPAIV that was not isolated from gallinaceous poultry may yield a high-pathogenic phenotype in chickens.
    • 64  Londt BZ, Banks J, Alexander DJ. Highly pathogenic avian influenza viruses with low virulence for chickens in in vivo tests. Avian Pathol.36(5),347–350 (2007).▪▪ Describes four natural avian strains with polybasic HACS but low virulence in chickens, indicating that further adaptation is required, paralleling the experimental studies.
    • 65  Kawaoka Y, Naeve CW, Webster RG. Is virulence of H5N2 influenza viruses in chickens associated with loss of carbohydrate from the hemagglutinin? Virology139(2),303–316 (1984).
    • 66  Li SQ, Orlich M, Rott R. Generation of seal influenza virus variants pathogenic for chickens, because of hemagglutinin cleavage site changes. J. Virol.64(7),3297–3303 (1990).
    • 67  Kawaoka Y, Webster RG. Interplay between carbohydrate in the stalk and the length of the connecting peptide determines the cleavability of influenza virus hemagglutinin. J. Virol.63(8),3296–3300 (1989).
    • 68  Wasilenko JL, Lee CW, Sarmento L et al.NP, PB1, and PB2 viral genes contribute to altered replication of H5N1 avian influenza viruses in chickens. J. Virol.82(9),4544–4553 (2008).
    • 69  Li Z, Jiang Y, Jiao P et al. The NS1 gene contributes to the virulence of H5N1 avian influenza viruses. J. Virol.80(22),11115–11123 (2006).
    • 70  Grambas S, Hay AJ. Maturation of influenza A virus hemagglutinin – estimates of the pH encountered during transport and its regulation by the M2 protein. Virology190(1),11–18 (1992).
    • 71  DuBois RM, Zaraket H, Reddivari M et al. Acid stability of the hemagglutinin protein regulates H5N1 influenza virus pathogenicity. PLoS Pathog.7(12),e1002398 (2011).
    • 72  Ma W, Brenner D, Wang Z et al. The NS segment of an H5N1 highly pathogenic avian influenza virus (HPAIV) is sufficient to alter replication efficiency, cell tropism, and host range of an H7N1 HPAIV. J. Virol.84(4),2122–2133 (2010).
    • 73  Deshpande KL, Naeve CW, Webster RG. The neuraminidases of the virulent and avirulent A/chicken/Pennsylvania/83 (H5N2) influenza A viruses: sequence and antigenic analyses. Virology147(1),49–60 (1985).
    • 74  Munier S, Larcher T, Cormier-Aline F et al. A genetically engineered waterfowl influenza virus with a deletion in the stalk of the neuraminidase has increased virulence for chickens. J. Virol.84(2),940–952 (2010).
    • 75  Sorrell EM, Song H, Pena L, Perez DR. A 27-amino-acid deletion in the neuraminidase stalk supports replication of an avian H2N2 influenza A virus in the respiratory tract of chickens. J. Virol.84(22),11831–11840 (2010).
    • 76  Alexander DJ. Report on avian influenza in the eastern hemisphere during 1997–2002. Avian Dis.47(Suppl. 3),792–797 (2003).
    • 77  Senne DA, Suarez DL, Pedersen JC, Panigrahy B. Molecular and biological characteristics of H5 and H7 avian influenza viruses in live-bird markets of the northeastern United States, 1994–2001. Avian Dis.47(Suppl. 3),898–904 (2003).
    • 101  OIE. World Organisation for Animal Health. Update on highly pathogenic avian influenza in animals (types H5 and H7). www.oie.int/animal-health-in-the-world/update-on-avian-influenza/2011 (Accessed 18 January 2013)